Zenith Capital (TSXV:ZENI.P) FCF Yield % : -127.55 (As of May. 28, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Zenith Capital FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Zenith Capital's Trailing 12-Month Free Cash Flow is C$-19.24 Mil, and Market Cap is C$15.09 Mil. Therefore, Zenith Capital's FCF Yield % for today is -127.55%.

The historical rank and industry rank for Zenith Capital's FCF Yield % or its related term are showing as below:

TSXV:ZENI.P' s FCF Yield % Range Over the Past 10 Years
Min: -127.55 Med: 0 Max: 0
Current: -127.55

TSXV:ZENI.P's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -14.445 vs TSXV:ZENI.P: -127.55

Zenith Capital's FCF Margin % for the quarter that ended in Jan. 2024 was 0.00%.

Zenith Capital FCF Yield % Historical Data

The historical data trend for Zenith Capital's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Capital FCF Yield % Chart

Zenith Capital Annual Data

Trend

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

FCF Yield %

Get a 7-Day Free Trial

-18.21

-30.46

-6.67

-80.22

Zenith Capital Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
FCF Yield %	Get a 7-Day Free Trial															-40.42	-224.24	-102.68	-53.40	-106.56

Competitive Comparison of Zenith Capital's FCF Yield %

For the Biotechnology subindustry, Zenith Capital's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zenith Capital's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zenith Capital's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Zenith Capital's FCF Yield % falls into.

Zenith Capital FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Zenith Capital's FCF Yield % for the fiscal year that ended in Apr. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-12.508	/	15.592395
	=	-80.22%

Zenith Capital's annualized FCF Yield % for the quarter that ended in Jan. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-4.263	*	4	/	16.002105
	=	-106.56%

Zenith Capital FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Zenith Capital FCF Yield % Related Terms

Thank you for viewing the detailed overview of Zenith Capital's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenith Capital (TSXV:ZENI.P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenith Capital Corporation (TSXV:ZENI.P) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2475 Queens Avenue, West Vancouver, BC, CAN, V7V 2Y9

Website

https://www.zenithepigenetics.com

Zenith Capital Corporation is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics for the treatment of cancer and other disorders with significant unmet medical needs. The company is developing various novel combinations of BET inhibitors with other targeted agents. The lead compound, ZEN-3694, is in clinical development for mCRPC in combination with androgen receptor inhibitor, XTANDI, with Astellas and Newsoara as collaborators; triple-negative breast cancer in combination with the PARP inhibitor TALZENNA with Pfizer as a collaborator; androgen receptor independent mCRPC in combination with immune checkpoint inhibitor KEYTRUDA and XTANDI with University of California, San Francisco as a collaborator.

Zenith Capital (TSXV:ZENI.P) Headlines

No Headlines